Regulus Therapeutics to Present at the Leerink Partners 2025 Global Healthcare Conference
Provided By PR Newswire
Last update: Mar 4, 2025
SAN DIEGO, March 4, 2025 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced that members of the management team will participate in a fireside chat at the Leerink Partners 2025 Global Healthcare Conference on Tuesday, March 11th at 3:40 p.m. ET.
Read more at prnewswire.com
